Effect of propolis and caffeic acid phenethyl ester (CAPE) on NFκB activation by HTLV-1 Tax

Antiviral Research

Volumn 90, Issue 3, 2011, Pages 108-115

  Shvarzbeyn, Jenny ^a   Huleihel, Mahmoud ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Caffeic acid phenethyl ester (CAPE); HTLV 1; NF B; Propolis; Tax

Indexed keywords

CAFFEIC ACID PHENETHYL ESTER; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROPOLIS; TAX PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN TRANSPORT; TUMOR CELL; VIRUS ACTIVATION;

ANTI-RETROVIRAL AGENTS; CAFFEIC ACIDS; CELL LINE; GENE PRODUCTS, TAX; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; NF-KAPPA B; PHENYLETHYL ALCOHOL; PROPOLIS; TRANSCRIPTIONAL ACTIVATION;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 79953846543     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.03.177     Document Type: Article

References (55)

1. Ang E.S., Pavlos N.J., Chai L.Y., Qi M., Cheng T.S., Steer J.H., Joyce D.A., Zheng M.H., Xu J. Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL-induced NF-kappaB and NFAT activity. J. Cell. Physiol. 2009, 221:642-649.
2. Azran I., Schavinsky-Khrapunsky Y., Aboud M. Role of Tax protein in human T-cell leukemia virus type-1 leukemogenicity. Retrovirology 2004, 1:20-43.
3. Bassères D.S., Ebbs A., Levantini E., Baldwin A.S. Requirement of the NF-kappaB subunit p65/RelA for K-Ras-induced lung tumorigenesis. Cancer Res. 2010, 70:3537-3546.
4. Baylor N.W., Fu T., Yan Y.D., Ruscetti F.W. Inhibition of human T cell leukemia virus by the plant flavonoid baicalin (7-glucuronic acid-5,6-dihydroxyflavone). J. Infect. Dis. 1992, 165:433-437.
5. Bex F., McDowall A., Burny A., Gaynor R. The human T-cell leukemia virus type 1 transactivator protein Tax colocalizes in unique nuclear structures with NF-kappaB proteins. J. Virol. 1997, 71:3484-3497.
6. Campbell K.J., Perkins N.D. Regulation of NF-kappaB function. Biochem. Soc. Symp. 2006, 73:165-180.
7. Catley M.C., Cambridge L.M., Nasuhara Y., Ito K., Chivers J.E., Beaton A., Holden N.S., Bergmann M.W., Barnes P.J., Newton R. Inhibitors of protein kinase C (PKC) prevent activated transcription: role of events downstream of NF-kappaB DNA binding. J. Biol. Chem. 2004, 279:18457-18466.
8. Chalet T., Thomas A. Proteasome inhibitor PS-341, a potential therapeutic agent for adult T-cell leukemia. Cancer Res. 2002, 62:1083-1086.
9. Chu Z.L., DiDonato J.A., Hawiger J., Ballard D.W. The tax oncoprotein of human T-cell leukemia virus type 1 associates with and persistently activates IkappaB kinases containing IKKalpha and IKKbeta. J. Biol. Chem. 1998, 273:15891-15894.
10. Chu Z.L., Shin Y.A., Yang J.M., DiDonato J.A., Ballard D.W. IKKgamma mediates the interaction of cellular IkappaB kinases with the tax transforming protein of human T cell leukemia virus type 1. J. Biol. Chem. 1999, 274:15297-15300.
11. de Jong S.J., Albrecht J.C., Schmidt M., Müller-Fleckenstein I., Biesinger B. Activation of noncanonical NF-kappaB signaling by the oncoprotein Tio. J. Biol. Chem. 2010, 28:16495-16503.
12. Grunberger D., Banerjee R., Eisinger K., Oltz E.M., Efros L., Caldwell M., Estevez V., Nakanishi K. Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis. Experientia 1988, 44:230-232.
13. Harhaj E.W., Sun S.C. IKKgamma serves as a docking subunit of the IkappaB kinase (IKK) and mediates interaction of IKK with the human T-cell leukemia virus tax protein. J. Biol. Chem. 1999, 274:22911-22914.
14. Higuchi M., Fujii M. Distinct functions of HTLV-1 tax1 from HTLV-2 tax2 contribute key roles to viral pathogenesis. Retrovirology 2009, 6:117-128.
15. Horie R., Watanabe T., Umezawa K. Blocking NF-kappaB as a potential strategy to treat adult T-cell leukemia/lymphoma. Drug News Perspect. 2006, 19:201-209.
16. Huleihel M., Eshanu V. Effect of propolis extract on malignant cell transformation by moloney murine sarcoma virus. Arch. Virol. 2001, 146:1-10.
17. Jin D.Y., Giordano V.G., Kibler K.V., Nakano H., Jeang K.T. Role of adapter function in oncoprotein-mediated activation of NF-kappaB. Human T-cell leukemia virus type I Tax interacts directly with IkappaB kinase gamma. J. Biol. Chem. 1999, 274:17402-17405.
18. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-kappaB activity. Annu. Rev. Immunol. 2000, 18:621-663.
19. Lee Y., Shin D.H., Kim J.H., Hong S., Choi D., Kim Y.J., Kwak M.K., Jung Y. Caffeic acid phenethyl ester-mediated Nrf2 activation and IkappaB kinase inhibition are involved in NFkappaB inhibitory effect: structural analysis for NFkappaB inhibition. Eur. J. Pharmacol. 2010, 643:21-28.
20. Li H.C., Yashiki S., Sonoda J., Lou H., Ghosh S.K., Byrnes J.J., Lema C., Fujiyoshi T., Karasuyama M., Sonoda S. Green tea polyphenols induce apoptosis in vitro in peripheral blood T lymphocytes of adult T-cell leukemia patients. Jpn. J. Cancer Res. 2000, 91:34-40.
21. Li Q., Verma I.M. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2002, 2:725-734.
22. Libério S.A., Pereira A.L., Aráujo M.J., Dutra R.P., Nascimento F.R., Monteiro-Neto V., Ribeiro M.N., Gonçalves A.G., Guerra R.N. The potential use of propolis as a cariostatic agent and its actions on mutants group streptococci. J. Ethnopharmacol. 2009, 125:1-9.
23. Márquez N., Sancho R., Macho A., Calzado M.A., Fiebich B., Muñoz E. Caffeic acid phenethyl ester inhibits T-cell activation by targeting both nuclear factor of activated T-cells and NF-kappaB transcription factors. J. Pharmacol. Exp. Ther. 2004, 308:993-1001.
24. Mor-Vaknin N., Torgeman A., Galron D., Löchelt M., Flügel R.M., Aboud M. The long terminal repeats of human immunodeficiency virus type-1 and human T-cell leukemia virus type-I are activated by 12-O-tetradecanoylphorbol-13-acetate through different pathways. Virology 1997, 1997:337-344.
25. Natarajan K., Singh S., Burke T.J., Grunberger D., Aggarwal B. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappaB. Proc. Natl. Acad. Sci. USA 1996, 93:9090-9095.
26. Norris P.J., Hirschkorn D.F., Devita D.A., Lee T.H., Murphy E.L. Human T cell leukemia virus type 1 infection drives spontaneous proliferation of natural killer cells. Virulence 2010, 1:19-28.
27. Olivier S., Robe P., Bours V. Can NF-kappaB be a target for novel and efficient anti-cancer agents?. Biochem. Pharmacol. 2006, 72:1054-1068.
28. Onori P., DeMorrow S., Gaudio E., Franchitto A., Mancinelli R., Venter J., Kopriva S., Ueno Y., Alvaro D., Savage J., Alpini G., Francis H. Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-kappaB and induction of apoptosis. Int. J. Cancer 2009, 125:565-576.
29. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18:6853-6866.
30. Peloponese J.M., Jeang K.T. Role for Akt/protein kinase B and activator protein-1 in cellular proliferation induced by the human T-cell leukemia virus type 1 tax oncoprotein. J. Biol. Chem. 2006, 281:8927-8938.
31. Pratsinis H., Kletsas D., Melliou E., Chinou I. Antiproliferative activity of Greek propolis. J. Med. Food 2010, 13:286-290.
32. Puvvada S.D., Funkhouser W.K., Greene K., Deal A., Chu H., Baldwin A.S., Tepper J.E., O'Neil B.H. NF-kB and Bcl-3 activation are prognostic in metastatic colorectal cancer. Oncology 2010, 78:181-188.
33. Russo A., Troncoso N., Sanchez F., Garbarino J.A., Vanella A. Propolis protects human spermatozoa from DNA damage caused by benzo[a]pyrene and exogenous reactive oxygen species. Life Sci. 2006, 78:1401-1406.
34. Santoro M.G., Rossi A., Amici C. NF-kappaB and virus infection: who controls whom. EMBO J. 2003, 22:2552-2560.
35. Schavinsky-Khrapunsky Y., Gold E., Ben-Aroya Z., Torgeman A., Aboud M., Huleihel M. Activation of HTLV-I long terminal repeat by apoptosis inducing agents: mechanism and implications for HTLV-I pathogenicity. Int. J. Mol. Med. 2003, 11:3-11.
36. Schubert S.Y., Neeman I., Resnick N. A novel mechanism for the inhibition of NF-kappaB activation in vascular endothelial cells by natural antioxidants. FASEB J. 2002, 16:1931-1933.
37. Sheppard K.A., Rose D.W., Haque Z.K., Kurokawa R., McInerney E., Westin S., Thanos D., Rosenfeld M.G., Glass C.K., Collins T. Transcriptional activation by NF-kappaB requires multiple coactivators. Mol. Cell. Biol. 1999, 19:6367-6378.
38. Song J.J., Cho J.G., Hwang S.J., Cho C.G., Park S.W., Chae S.W. Inhibitory effect of caffeic acid phenethyl ester (CAPE) on LPS-induced inflammation of human middle ear epithelial cells. Acta Otolaryngol. 2008, 128:1303-1307.
39. Sonoda J., Koriyama C., Yamamoto S., Kozako T., Li H.C., Lema C., Yashiki S., Fujiyoshi T., Yoshinaga M., Nagata Y., Akiba S., Takezaki T., Yamada K., Sonoda S. HTLV-1 provirus load in peripheral blood lymphocytes of HTLV-1 carriers is diminished by green tea drinking. Cancer Sci. 2004, 95:596-601.
40. Suzuki T., Hirai H., Murakami T., Yoshida M. Tax protein of HTLV-1 destabilizes the complexes of NF-kappaB and I kappa B-alpha and induces nuclear translocation of NF-kappaB for transcriptional activation. Oncogene 1995, 10:1199-1207.
41. Szliszka E., Czuba Z.P., Domino M., Mazur B., Zydowicz G., Krol W. Ethanolic extract of propolis (EEP) enhances the apoptosis-inducing potential of TRAIL in cancer cells. Molecules 2009, 14:738-754.
42. Tabakin-Fix Y., Azran-Shaish I., Schavinsky-Khrapunsky Y., Chamias R., Gohari L., Huleihel M., Li-Weber M., Aboud M. Human T-cell leukemia virus type 1: transition from latent infection to pathogenic progression and implications for molecular therapy. Curr. Cancer Ther. Rev. 2006, 2:101-113.
43. Tabakin-Fix Y., Huleihel M., Aboud M. Activation of simian virus 40 promoter by HTLV-I Tax protein: role of NF-kappaB and CBP. Biochem. Biophys. Res. Commun. 2004, 318:1052-1056.
44. Tanaka K., Kawakami T., Tateishi K., Yashiroda H., Chiba T. Control of IkappaBalpha proteolysis by the ubiquitin-proteasome pathway. Biochimie 2001, 83:351-356.
45. Tergaonkar V. NF-kappaB pathway: a good signaling paradigm and therapeutic target. Int. J. Biochem. Cell Biol. 2006, 38:1647-1653.
46. Torgeman A., Mor-Vaknin N., Zelin E., Ben-Aroya Z., Löchelt M., Flügel R.M., Aboud M. Sp1-p53 heterocomplex mediates activation of HTLV-I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate that is antagonized by protein kinase C. Virology 2001, 281:10-20.
47. Umezawa K., Ariga A., Matsumoto N. Naturally occurring and synthetic inhibitors of NF-kappaB functions. Anticancer Drug Des. 2000, 15:239-244.
48. Umthong S., Puthong S., Chanchao C. Trigona laeviceps propolis from Thailand: antimicrobial, antiproliferative and cytotoxic activities. Am. J. Chin. Med. 2009, 37:855-865.
49. Wang T., Li Q., Hao G., Zhai J. Antitumor activity of decoy oligodeoxynucleotides targeted to NF-kappaB in vitro and in vivo. Asian Pac. J. Cancer Prev. 2010, 11:193-200.
50. Watters K.M., Dean J., Gautier V., Hall W.W., Sheehy N. Tax 1-independent induction of vascular endothelial growth factor in adult T-cell leukemia caused by human T-cell leukemia virus type 1. J. Virol. 2010, 84:5222-5228.
51. Yamamoto Y., Gaynor R. IkappaB kinases: key regulators of the NF-kappaB pathway. Trends Biochem. Sci. 2004, 29:72-79.
52. Yang C., Wu J., Zhang R., Zhang P., Eckard J., Yusuf R., Huang X., Rossman T., Frenkel K. Caffeic acid phenethyl ester (CAPE) prevents transformation of human cells by arsenite (As) and suppresses growth of As-transformed cells. Toxicology 2005, 213:81-96.
53. Yoshida M. Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis. Oncogene 2005, 24:5931-5937.
54. Zandi E., Rothwarf D.M., Delhase M., Hayakawa M., Karin M. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 1997, 91:243-252.
55. Zhong H., May M.J., Jimi E., Ghosh S. The phosphorylation status of nuclear NF-kappaB determines its association with CBP/p300 or HDAC-1. Mol. Cell 2002, 9:625-636.